Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Tuesday, December 6, 2022
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing
Thursday, June 2, 2022
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies
Thursday, September 30, 2021
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes
Friday, July 31, 2020
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials
Friday, July 24, 2020
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2
Tuesday, October 22, 2019
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology
Friday, June 28, 2019
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms
Friday, April 5, 2019
Passing of Dr Sydney Brenner, Nobel Laureate, Renowned Pioneer in Molecular Biology, A*Star Senior Fellow
Monday, January 21, 2019
Branched-Chain Amino Acids Found to Regulate the Development and Progression of Cancer

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: